Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Pfizer announces positive results from phase 3 study of 20-valent pneumococcal conjugate vaccine

      Pfizer announces positive results from phase 3 study of 20-valent pneumococcal conjugate vaccine

      Medical Dialogues Bureau22 March 2020 9:00 AM IST
      New York: Pfizer Inc. has announced top-line results from one of its Phase 3 studies, which evaluated the safety and immunogenicity of its 20-valent...
      Coronavirus: Govt puts immediate ban on Export of  Masks, Ventilators and textile raw material for masks and coveralls

      Coronavirus: Govt puts immediate ban on Export of Masks, Ventilators and textile raw material for masks and coveralls

      Medical Dialogues Bureau21 March 2020 2:22 PM IST
      Delhi: To prevent any kind of shortage in the country in the scenario of coronavirus, the export of Ventilators, Surgical/Disposable Masks (2/3...
      Ibuprofen and Covid-19: Drugmaker Sanofi defends Molecule, WHO updates its stand

      Ibuprofen and Covid-19: Drugmaker Sanofi defends Molecule, WHO updates its stand

      Medical Dialogues Bureau21 March 2020 1:35 PM IST
      New Delhi: Responding to the World Health Organisation statement earlier that recommended avoidance of Ibuprofen due to its suspected worserning...
      CDSCO issues clarification on the requirement of process validation report for permission to conduct Clinical trial/BA-BE studies

      CDSCO issues clarification on the requirement of process validation report for permission to conduct Clinical trial/BA-BE studies

      Medical Dialogues Bureau21 March 2020 12:00 PM IST
      New Delhi: Through a recent notice Central Drugs Standard Control Organization (CDSC0), Directorate General of Health Services has clarified the...
      Merck Announces positive results for Gefapixant  Phase 3 Trial to treat Chronic Cough

      Merck Announces positive results for Gefapixant Phase 3 Trial to treat Chronic Cough

      Medical Dialogues Bureau21 March 2020 10:15 AM IST
      Kenilworth: Merck, known as MSD outside the United States and Canada, has announced top-line efficacy results from two ongoing pivotal Phase 3...
      AstraZenecas Phase III CASPIAN trial final analysis shows Imfinzi confirmed survival benefit for small cell lung cancer patients

      AstraZeneca's Phase III CASPIAN trial final analysis shows Imfinzi confirmed survival benefit for small cell lung cancer patients

      Medical Dialogues Bureau21 March 2020 9:00 AM IST
      Imfinzi confirmed a sustained overall survival benefit in the final analysis of the Phase III CASPIAN trial in 1st-line extensive-stage small cell...
      Dr Reddys Labs launches Naloxone Hydrochloride Injection in US Market

      Dr Reddy's Labs launches Naloxone Hydrochloride Injection in US Market

      Medical Dialogues Bureau21 March 2020 9:00 AM IST
      Hyderabad and Princeton: Dr Reddy's Laboratories Ltd. has announced the launch of Naloxone Hydrochloride Injection USP, 2 mg/2 mL (1 mg/mL)...
      Prices of Alcohols used in manufacturing hand sanitizers capped under the Essential Commodities Act

      Prices of Alcohols used in manufacturing hand sanitizers capped under the Essential Commodities Act

      Medical Dialogues Bureau20 March 2020 2:23 PM IST
      This will help the manufacturers of hand sanitizers to keep prices of their and product at reasonable and within the reach of the common people.
      Dr Reddys Labs launches Pyrimethamine Tablets in US

      Dr Reddy's Labs launches Pyrimethamine Tablets in US

      Medical Dialogues Bureau20 March 2020 12:14 PM IST
      Dr Reddy’s Pyrimethamine Tablets USP, is available in 25 mg dose in bottle count sizes of 30 and 100.
      API should be declared strategic sector especially in light of Coronavirus: CII

      API should be declared strategic sector especially in light of Coronavirus: CII

      Medical Dialogues Bureau20 March 2020 11:00 AM IST
      New Delhi: The coronavirus outbreak makes a compelling case for the government to declare active pharmaceutical ingredient (API) as a strategic sector...
      Abbott gets USFDA emergency use authorization for COVID-19 molecular test

      Abbott gets USFDA emergency use authorization for COVID-19 molecular test

      Medical Dialogues Bureau20 March 2020 10:15 AM IST
      The Abbott m2000 RealTime System is a molecular solution featuring a broad menu of tests, including ones for infectious diseases.
      Roche begins Phase III clinical trial of Actemra in hospitalised patients with severe COVID-19 pneumonia

      Roche begins Phase III clinical trial of Actemra in hospitalised patients with severe COVID-19 pneumonia

      Medical Dialogues Bureau20 March 2020 10:00 AM IST
      Basel: Roche has announced that it is working with the Food & Drug Administration (FDA) to initiate a randomised, double-blind, placebo-controlled...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok